| Adrenal Cortical Neoplasm studied in …STUDIED_INderived105 of 105show fewer |
|---|
| → studied in | NCT06487481Phase 1 · recruiting Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07715903Phase 1 · not yet recruiting Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06900595Phase 2 · recruiting Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07743138Phase 2 · not yet recruiting STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL) · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286814Phase 2 · recruiting PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06279442completed Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort · condition mapped PROBABILISTIC · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped ONTOLOGY_EXACT · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453674recruiting German Adrenocortical Carcinoma Registry · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03333616Phase 2 · active not recruiting Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02721732Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050268recruiting Familial Investigations of Childhood Cancer Predisposition · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06041516Phase 1 · recruiting A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00700414recruiting International Pediatric Adrenocortical Tumor Registry · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189403Phase 1 · recruiting A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer · condition mapped PROBABILISTIC · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897321Phase 1 · recruiting B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00457587active not recruiting Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00568139active not recruiting Evaluation of Side Effects of Mitotane · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00669266recruiting Adrenal Tumors - Pathogenesis and Therapy · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03127774Phase 2 · active not recruiting Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02756754NA · completed Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06066333Phase 2 · recruiting Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ONTOLOGY_EXACT · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02673333Phase 2 · active not recruiting Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04358107active not recruiting Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC) · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06006013Phase 2 · recruiting Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04187404Phase 1/Phase 2 · terminated A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05036434Phase 2 · active not recruiting Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07335679recruiting Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma · condition mapped ONTOLOGY_EXACT · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02324647completed Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03746431Phase 1 · terminated A Phase 1 Study of [225Ac]-FPI-1434 Injection · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06333314Phase 2 · recruiting Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085572Phase 2 · recruiting Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer · condition mapped ONTOLOGY_EXACT · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07141147NA · not yet recruiting A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery. · condition mapped PROBABILISTIC · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072143recruiting An International Study on Pediatric Patients With Rare Tumors. · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05634577Phase 2 · terminated A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06831175Phase 2 · recruiting Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma · condition mapped ONTOLOGY_EXACT · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06587802Phase 2 · recruiting Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05563467Phase 2 · recruiting Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma. · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03370718Phase 2 · completed Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma · condition mapped PROBABILISTIC · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05999292Phase 1 · terminated Phase 1 Study of 68Ga-R8760 · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00924989Phase 3 · completed A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012397Phase 2 · terminated Milademetan in Advanced/Metastatic Solid Tumors · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06576336Phase 4 · completed A Randomized Clinical Trial About Use of 3D Laparoscopy Versus 2D Laparoscopy in Adrenal Surgery · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03612232Phase 2 · unknown Cabozantinib in Advanced Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03723941Phase 3 · completed Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05913427Phase 2 · recruiting Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC) · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04318730Phase 2 · unknown Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06229405unknown Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data · condition mapped ONTOLOGY_EXACT · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00304070Phase 3 · completed Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04373265Phase 1 · completed Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06050057unknown Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05991856recruiting Multifaceted Comparison of Ultrasound-guided Ablation and Laparoscopic Adrenalectomy for Aldosterone-producing Adenoma · condition mapped PROBABILISTIC · 105 trials mapped (37 active) | — | — | Adrenal Cortical Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05839886unknown The Adverse Event of Mitotane Therapy in Patients With Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05763524unknown European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05344027completed The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04447014terminated Natural History Study of Children and Adults With Adrenocortical Cancer (ACC) · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05660889unknown Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361083early Phase 1 · completed First-in-human Evaluation of [18F]CETO · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02637531Phase 1 · unknown A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549 · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04890444unknown China Adrenal Disease Registry · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04666220unknown VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma · condition mapped PROBABILISTIC · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02468193Phase 2 · completed Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03474237enrolling by invitation A Prospective Cohort Study for Patients With Adrenal Diseases · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02015026completed Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03830593completed Laparoscopic Adrenalectomy for Large Adrenal Tumors. · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01833832Phase 2 · completed Surgery and Heated Chemotherapy for Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02720484Phase 2 · terminated Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer · condition mapped PROBABILISTIC · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453895Phase 2 · completed Sunitinib in Refractory Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02747355unknown Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01262235Phase 1/Phase 2 · completed A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517332unknown Circulating Tumor DNA Exposure in Peripheral Blood · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003453Phase 2 · terminated Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03257891Phase 2 · unknown Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01898715Phase 1 · completed Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831179Phase 1 · withdrawn Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03145285Phase 2 · unknown Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00777244Phase 3 · unknown Efficacy of Adjuvant Mitotane Treatment (ADIUVO) · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01514526Phase 2 · completed Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02030587NA · unknown Laparoscopic Adrenalectomy Versus Radiofrequency Ablation · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445718completed Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02150213Phase 2 · completed Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00094497Phase 3 · completed Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) · condition mapped ONTOLOGY_EXACT · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01528956completed Studying Genes in Samples From Younger Patients With Adrenocortical Tumor · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01832974Phase 1 · terminated Possible New Therapy for Advanced Cancer · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00469469Phase 2 · withdrawn Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00831844Phase 2 · completed Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00848016Phase 2 · completed Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00778817Phase 2 · terminated IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01048892Phase 1 · completed Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002608Phase 2 · completed Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01255137Phase 2 · completed Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091182Phase 2 · completed Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped CURATED_BROADER · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002921Phase 2 · terminated S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00071058Phase 2 · completed Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436410early Phase 1 · completed Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436657Phase 1 · completed Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00324012Phase 2 · completed Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003038Phase 1 · completed Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454103Phase 1/Phase 2 · completed Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00786110Phase 2 · unknown Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00768365completed Cardiovascular Risk in Patients With Non-Functional Adrenal Incidentaloma · condition mapped ALIAS · 105 trials mapped (37 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001339Phase 2 · completed A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection · condition mapped ONTOLOGY_EXACT · 105 trials mapped (37 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |